Related Experiment Video
Updated: Feb 1, 2026
Organotypic Slice Cultures to Study Oligodendrocyte Dynamics and Myelination
Published on: August 25, 2014
Elevated serum complement shows promise as a potential clinically practical biomarker for disease activity in myelin
Yiying Huang1, Linling Wang1, Marzena Fabis-Pedrini2
1Department of Neurology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Background:
We aim to elucidate the differences in complement activation between myelin oligodendrocyte glycoprotein antibody-related disease (MOGAD) and neuromyelitis optic spectrum diseases (NMOSD), and explore the relationship between complement levels and disease activity in MOGAD.
Methods:
We retrospectively included 171 records of commonly used serum complement indicators, immunoglobulin, and systemic inflammatory markers from 96 MOGAD patients, 185 records from 97 anti - Aquaporins - 4 IgG (AQP4 - IgG) seropositive NMOSD cases, and 15 records from 11 AQP4 - IgG seronegative NMOSD cases.
Results:
MOGAD patients exhibited higher C3 (acute phase, p = 0.003) and C4 (acute phase, p < 0.001; whole course, p < 0.001) levels than NMOSD patients. In the MOGAD cohort, elevated CH50 levels were found in 76.47 % (130/170) cases, with higher frequencies during the acute phase 80.82 % (59/73). In the acute phase, MOGAD patients showed increased C4 (p = 0.022), CH50 (p = 0.021), and IgG (p = 0.031) levels. We also observed the dynamic fluctuations in complement concentrations after clinical attacks in MOGAD, with complement concentrations peaked during the acute phase and declined during remission (C3, 81.82 %, 9/11; C4, 63.64 %, 7/11; CH50, 72.73 %, 8/11). Positive correlations were observed between complement levels (p < 0.05) and IgG, CRP, ESR, and cerebrospinal fluid white blood cell count in MOGAD patients. Patients with higher CH50 levels tended to experience earlier recurrence than those with lower CH50 levels (log-rank p = 0.076).
Conclusions:
Clinically practical complement indicators can reflect disease activity, and CH50 can serve as prognostic candidate biomarkers for relapse in MOGAD.
More Related Videos
Related Concept Videos
01:23Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
03:12Freezing Point Depression and Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...
01:24Chronic Kidney Disease II: Clinical Manifestations
01:27Complement System
01:10Thermodynamics: Chemical Potential and Activity
The thermodynamic equilibrium constant is more accurately defined in terms of activity rather than concentration.
00:49Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...